Skip to main content

PharmStars — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

55
Companies
$106.4M
Total invested
$2.3M
Avg. check
36
Industries
Health Care 20Medical 9Artificial Intelligence (AI) 6Software 5Medical Device 5Information Technology 4+30 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 124 of 55
Innsightful
September 2024

Innsightful develops products and digital tools to help manage an individual's stress and moods.

Artificial Intelligence (AI) · SunnyvaleNon-equity Assistance
OmicsChart
July 2024

Patient-centric cancer data and analytics platform for translational cancer biologists

Bioinformatics · CardiffNon-equity Assistance
Akkure
July 2024

Akkure is a patient-centric digital platform.

Artificial Intelligence (AI) · DublinNon-equity Assistance
Neuroventis
July 2022

Neuroventis operates as a digital platform for neurology.

Health Care · OverijseNon-equity Assistance
Orbit Health
July 2022

Orbit Health focuses on developing an artificial intelligence solution that assists parkinson's disease patients.

Artificial Intelligence (AI) · MunichNon-equity Assistance
Vistim Labs
June 2023

Vistim Labs is a MedTech diagnostic company that helps to detect, treat, and track neurological disorders.

Health Diagnostics · Salt Lake City$10K Grant
Whyze Health
June 2026

Whyze Health is a healthcare firm that uses AI tools to connect healthcare ecosystem and provide better treatment to patients.

Artificial Intelligence (AI) · DublinSeed
Nivi
June 2023

Nivi is a digital health company that enables every person to realize their aspirations for better health.

Big Data · BostonNon-equity Assistance
CROMODATA
June 2025

CROMODATA turning health data into action for patients across LATAM.

Data Mining · Buenos Aires$1.2M Pre-Seed
SmartTab
May 2022

SmartTab is a digital drug delivery company which develops innovative wireless ingestible drug delivery and monitoring systems.

Electronics · Denver$175K Equity Crowdfunding
Comend
April 2023

Comend builds collaborative tools for the rare disease community and researchers to bring new treatments to market.

Apps · Toronto$765K Pre-Seed
Accexible
March 2023

Accexible is a focuses on the development of technology.

Biotechnology · Bilbao$20K Equity Crowdfunding
GPx
March 2026

GPx is a digital therapeutics company that revolutionizes remote chronic disease management with bloodless blood tests.

Biotechnology · BostonNon-equity Assistance
Deliberate AI
February 2025

Ambient Multimodal AI for Mental Health

Biopharma · New YorkSeed
MiMARK
September 2025

MiMARK focuses on improving the accuracy and efficiency of diagnostics for endometrial cancer.

Biotechnology · Barcelona$394K Seed
JOGO Health
July 2025

JOGO Health is a digital neurology company reducing surgeries and medications.

Artificial Intelligence (AI) · Old Bridge$2.1M Venture - Series Unknown
Local Infusion
June 2025

Technology-driven infusion therapy company

Health Care · Nashville$30.0M Series B
Scienta Lab
December 2023

Scienta Lab is an AI-powered platform pioneering Precision Immunology

Artificial Intelligence (AI) · Paris$4.3M Seed
Umedeor
July 2023

uMed enables healthcare providers to run patient research more efficiently through automating the clinical studies process

Health Care · London$12.5M Series A
ModoScript
December 2023

ModoScript is a B2B hardware SaaS remote treatment monitoring big data analytics solution for patients taking oral specialty therapeutics

Analytics · MiamiNon-equity Assistance
KEEP Labs
December 2023

The modern medicine cabinet and data platform.

Consumer Electronics · StratfordNon-equity Assistance
Celero Systems
December 2022

Celero Systems is a life sciences company that develops an ingestible system to detect and reverse opioid overdose.

Commercial · LincolnNon-equity Assistance
varient
December 2022

Varient accelerates both the symptom management journey for people with rare genetic diseases and the treatment development journey for R&D.

Personal Health · TorontoNon-equity Assistance
Promptly
December 2022

Promptly is a Real World Evidence company, collecting, integrating and analyzing data on the outcomes of care.

Analytics · PortoNon-equity Assistance

Where PharmStars invests

Health Care20
Medical9
Artificial Intelligence (AI)6
Software5
Medical Device5
Information Technology4

About PharmStars's portfolio

How many companies has PharmStars invested in?

PharmStars has invested in 55 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does PharmStars invest in?

PharmStars's top investment sectors include Health Care, Medical, Artificial Intelligence (AI), Software, Medical Device. The firm invests across 36 different industry categories.

What is PharmStars's largest investment?

Among tracked funding rounds, Local Infusion received $30.0M in a Series B round. PharmStars's total known invested capital is $106.4M.

What is the average investment size for PharmStars?

PharmStars's average investment size is $2.3M across its portfolio of 55 companies.

What are PharmStars's most recent investments?

Recent PharmStars portfolio additions include Innsightful, OmicsChart, Akkure, Neuroventis, Orbit Health. These companies were founded in 2020 or later.

Reach the founders behind these 55 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →